Smith also has a couple of electrolyte imbalances that must be addressed and corrected to reduce complications. First, Mrs. Smith has hyponatremia. According to Braun, Barstow, and Pyzocha (2015), heart failure-related hyponatremia is a hypervolemic form of hyponatremia that should be treated with diuretic, ACEI, and beta blocker therapy. The diuretic therapy immediately corrects the fluid and hyponatremia imbalance, and the other two medications treat the underlying cause, which is the activation of the renin-angiotensin-aldosterone system from CHF. The hyponatremia will be corrected with the furosemide, lisinopril, and metoprolol therapy. Mrs. Smith’s other electrolyte imbalance is hypomagnesemia. This must be corrected prior to administering furosemide, for furosemide can further deplete Mrs. Smith’s serum magnesium level, which will predispose her to hypomagnesemia-associated dysrhythmias (Fenestermacher & Hudson, 2016). Therefore, Mrs. Smith should also receive one gram of magnesium sulfate intravenously before the administration of